FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Evangelos Briasoulis

Research Profile

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Michalis Kastamoulas; Georgios Vartholomatos; Panagiotis Kanavaros; Dimitrios Arvanitis; Maria Bai; Evangelos Briasoulis; Georgios Chondrogiannis; Vasiliki Galani
Cytokine effects on cell survival and death of A549 lung carcinoma cells.
Leonidas Benetatos; Eleftheria Hatzimichael; Phillipe Loher; Eric Londin; Isidore Rigoutsos; George Vartholomatos; Evangelos Briasoulis
The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis.
Veronika Buxhofer-Ausch; Walter Jaeger; Valentinos Kounnis; Lena Secky; Martin Svoboda; Andreas G Tzakos; Katrin Wlcek; Evangelos Briasoulis; Theresia Thalhammer
Tumor-specific expression of organic anion-transporting polypeptides: transporters as novel targets for cancer therapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Evangelos Briasoulis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Michalis Kastamoulas; Georgios Vartholomatos; Panagiotis Kanavaros; Dimitrios Arvanitis; Maria Bai; Evangelos Briasoulis; Georgios Chondrogiannis; Vasiliki Galani
Cytokine effects on cell survival and death of A549 lung carcinoma cells.
Cytokine 2013;61(3):816-25.
2013: Leonidas Benetatos; Eleftheria Hatzimichael; Phillipe Loher; Eric Londin; Isidore Rigoutsos; George Vartholomatos; Evangelos Briasoulis
The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis.
Cellular and molecular life sciences : CMLS 2013;70(5):795-814.
2013: Veronika Buxhofer-Ausch; Walter Jaeger; Valentinos Kounnis; Lena Secky; Martin Svoboda; Andreas G Tzakos; Katrin Wlcek; Evangelos Briasoulis; Theresia Thalhammer
Tumor-specific expression of organic anion-transporting polypeptides: transporters as novel targets for cancer therapy.
Journal of drug delivery 2013;2013():863539.
2013: Eleftheria C Hatzimichael; Georgios Georgiou; Leonidas Benetatos; Evangelos Briasoulis
Gene mutations and molecularly targeted therapies in acute myeloid leukemia.
American journal of blood research 2013;3(1):29-51.
2012: Eleftheria C Hatzimichael; K Janczar; L E Karran; L Lattanzio; C Lo Nigro; M Merlano; M Monteverde; Alexandra Papoudou-Bai; P Schmid; R Shah; Justin Stebbing; Nelofer Syed; A Thompson; Daniela Vivenza; Maria Bai; M Bower; Evangelos Briasoulis; Aggeliki Dasoula; M J S Dyer; C ElguetaKarstegl; P J Farrell; Tim Crook
The collagen prolyl hydroxylases are novel transcriptionally silenced genes in lymphoma.
British journal of cancer 2012;107(8):1423-32.
2012: Eleftheria C Hatzimichael; Valentinos Kounnis; Laura Lattanzio; Alexandra Papoudou-Bai; Cristiana Lo Nigro; Leonidas Benetatos; Evangelos Briasoulis; Aggeliki Dasoula; George Dranitsaris; Tim Crook
Bcl2-interacting killer CpG methylation in multiple myeloma: a potential predictor of relapsed/refractory disease with therapeutic implications.
Leukemia & lymphoma 2012;53(9):1709-13.
2012: Helen Gogas; Haralabos P Kalofonos; Charisios Karanikiotis; Maria Karina; Paris Kosmidis; Christos Markopoulos; Christos Papadimitriou; Pavlos Papakostas; Dimitrios Pectasides; Epaminondas Samantas; George P Stathopoulos; Eleni Timotheadou; Dimitrios Bafaloukos; Anna Batistatou; Mattheos Bobos; Evangelos Briasoulis; Christos Christodoulou; Urania Dafni; Meletios A Dimopoulos; Anastasia G Eleftheraki; George Fountzilas
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial.
Breast cancer research and treatment 2012;132(2):609-19.
2012: Pinelopi Gogou; Emilios Pakos; Ioannis Panelos; Dimitrios Stefanou; Nikoforos Apostolikas; Anna Batistatou; Evangelos Briasoulis; Pericles G Tsekeris
Clinicopathologic study of E-cadherin/beta-catenin complex, and topoisomerase-II in a series of 71 liposarcoma cases.
World journal of surgical oncology 2012;10():28.
2011: Helena Linardou; Evangelos Briasoulis; Issa Dahabreh; Giannis Mountzios; Christos Papadimitriou; Savvas Papadopoulos; Dimitrios Bafaloukos; Paris Kosmidis; Samuel Murray
All about KRAS for clinical oncology practice: gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancer.
Cancer treatment reviews 2011;37(3):221-33.
2011: Andreas G Tzakos; Demosthenes Fokas; Charlie Johannes; Vassilios Moussis; Eleftheria Hatzimichael; Evangelos Briasoulis
Targeting oncogenic protein-protein interactions by diversity oriented synthesis and combinatorial chemistry approaches.
Molecules (Basel, Switzerland) 2011;16(6):4408-27.
2011: Valentinos Kounnis; Elli Ioachim; Martin Svoboda; Andreas Tzakos; Ioannis Sainis; Theresia Thalhammer; Georg Steiner; Evangelos Briasoulis
Expression of organic anion-transporting polypeptides 1B3, 1B1, and 1A2 in human pancreatic cancer reveals a new class of potential therapeutic targets.
OncoTargets and therapy 2011;4():27-32.
2010: Evangelos Briasoulis; Vassilis Golfinopoulos; Maria Karina; Pavlos Papakostas; Nicholas Pavlidis; George Fountzilas
Phase I trial of weekly irinotecan and paclitaxel combined with carboplatin in patients with advanced cancer: a Hellenic Cooperative Oncology Group Study.
Anti-cancer drugs 2010;21(8):785-9.
2010: Nicholas Pavlidis; Evangelos Briasoulis; George Pentheroudakis
Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21 Suppl 5():v228-31.
2010: Marios E Froudarakis; Evangelos Briasoulis
Advanced non-small cell lung cancer: on relapse rechallenge the tumor, not the patient.
BMC research notes 2010;3():195.
2010: Konstantinos H Katsanos; Evangelos Briasoulis; Pericles Tsekeris; Anna Batistatou; Maria Bai; Christos Tolis; Antonio Capizzello; Ioannis Panelos; Vasileios Karavasilis; Dimitrios Christodoulou; Epameinondas V Tsianos
Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvis.
Journal of experimental & clinical cancer research : CR 2010;29():68.
2010: Dimitrios Bafaloukos; Helena Linardou; Gerasimos Aravantinos; Christos Papadimitriou; Aristotelis Bamias; George Fountzilas; Haralabos P Kalofonos; Paris Kosmidis; Eleni Timotheadou; Thomas Makatsoris; Epaminondas Samantas; Evangelos Briasoulis; Christos Christodoulou; Pavlos Papakostas; Dimitrios Pectasides; Athanasios M Dimopoulos
A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study.
BMC medicine 2010;8():3.
2009: Evangelos Briasoulis; Periklis Pappas; Christian Puozzo; Christos Tolis; George Fountzilas; Urania Dafni; Marios Marselos; Nicholas Pavlidis
Dose-ranging study of metronomic oral vinorelbine in patients with advanced refractory cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(20):6454-61.
2009: Katerina Vareli; George Pilidis; Maria-Christina Mavrogiorgou; Evangelos Briasoulis; Ioannis Sainis
Molecular characterization of cyanobacterial diversity and yearly fluctuations of Microcystin loads in a suburban Mediterranean Lake (Lake Pamvotis, Greece).
Journal of environmental monitoring : JEM 2009;11(8):1506-12.
2009: Evangelos Briasoulis; Nicholas Pavlidis; E Felip
Cancers of unknown primary site: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20 Suppl 4():154-5.
2009: Vlassios Goulas; Vassiliki Exarchou; Anastassios N Troganis; Eleni Psomiadou; Theodore Fotsis; Evangelos Briasoulis; Ioannis P Gerothanassis
Phytochemicals in olive-leaf extracts and their antiproliferative activity against cancer and endothelial cells.
Molecular nutrition & food research 2009;53(5):600-8.
2009: George Fountzilas; Urania Dafni; Meletios A Dimopoulos; A Koutras; Dimosthenis Skarlos; Pavlos Papakostas; Helen Gogas; Dimitrios Bafaloukos; Anna Kalogera-Fountzila; Epaminondas Samantas; Evangelos Briasoulis; Dimitrios Pectasides; N Maniadakis; F Matsiakou; Gerasimos Aravantinos; Christos Papadimitriou; Maria Karina; Christos Christodoulou; Paris A Kosmidis; Haralabos P Kalofonos
A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study.
Breast cancer research and treatment 2009;115(1):87-99.
2009: Evangelos Briasoulis; D Kardamakis
The dawn of Clinical Oncology education in Greece.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2009;14(2):327-32.
2009: Christos Christodoulou; Ioannis Kostopoulos; Haralabos P Kalofonos; Evangelos Lianos; Mattheos Bobos; Evangelos Briasoulis; Helen Gogas; Evangelia Razis; Dimosthenis V Skarlos; George Fountzilas
Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation.
Oncology 2009;76(4):275-85.
2008: Gerasimos Aravantinos; George Fountzilas; Aristotelis Bamias; Irene Grimani; Spyridon Rizos; Haralabos P Kalofonos; Dimosthenis V Skarlos; Theofanis Economopoulos; Paris A Kosmidis; George P Stathopoulos; Evangelos Briasoulis; Dimitrios Pectasides; Epaminondas Samantas; Eleni Timotheadou; Christos Papadimitriou; Alexandros Papanikolaou; Adimchi Onyenadum; Pavlos Papakostas; Dimitrios Bafaloukos; Meletios A Dimopoulos
Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for first-line chemotherapy of advanced ovarian cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
European journal of cancer (Oxford, England : 1990) 2008;44(15):2169-77.
2008: Angelos Koutras; George Fountzilas; Urania Dafni; Meletios A Dimopoulos; Dimitrios Pectasides; George Klouvas; Pavlos Papakostas; Paris A Kosmidis; Epaminondas Samantas; Helen Gogas; Evangelos Briasoulis; Georgia Vourli; Theodoros Petsas; Nikolaos Xiros; Haralabos P Kalofonos
Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomised trials conducted by the Hellenic Cooperative Oncology Group.
Anticancer research 2008;28(5B):2913-20.
2008: Evangelos Briasoulis; George Fountzilas; A Bamias; M A Dimopoulos; N Xiros; Gerasimos Aravantinos; Epaminondas Samantas; H Kalofonos; T Makatsoris; N Mylonakis; P Papakostas; D Skarlos; I Varthalitis; Nicholas Pavlidis
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study.
Cancer chemotherapy and pharmacology 2008;62(2):277-84.
2008: Evangelos Briasoulis; Dimosthenis Ziogas; Michael Fatouros
Prophylactic surgery in the complex decision-making management of BRCA mutation carriers.
Annals of surgical oncology 2008;15(6):1788-90; author reply 1791-2.
2008: Evangelos Briasoulis; Nicholas Pavlidis; E Felip
Cancers of unknown primary site: ESMO clinical recommendation for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19 Suppl 2():ii106-7.
2008: George Fountzilas; Urania Dafni; Helen Gogas; Helena Linardou; Haralabos P Kalofonos; Evangelos Briasoulis; Dimitrios Pectasides; Epaminondas Samantas; Dimitrios Bafaloukos; George P Stathopoulos; Maria Karina; Christos Papadimitriou; Dimosthenis Skarlos; N Pisanidis; Pavlos Papakostas; Christos Markopoulos; E Tzorakoeleftherakis; K Dimitrakakis; P Makrantonakis; N Xiros; A Polichronis; I Varthalitis; Charisios Karanikiotis; Athanassios Meletios Dimopoulos
Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(5):853-60.
2008: Evangelos Briasoulis; Konstantinos Kamposioras; Vasilis Tzovaras; George Pafitanis; Angeliki Kostoula; Anestis Mavridis; Nicholas Pavlidis
CENP-B specific anti-centromere autoantibodies heralding small-cell lung cancer. A case study and review of the literature.
Lung cancer (Amsterdam, Netherlands) 2008;60(2):302-6.
2008: Evangelos Briasoulis; Dimitrios H Roukos
Contralateral prophylactic mastectomy: mind the genetics.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(11):1909-10; author reply 1910.
2008: Angela Apessos; Eirini Papadopoulou; Ioulia Belogianni; Sotiris Baratsis; John K Triantafillidis; Paris A Kosmidis; Eirini Karydas; Evangelos Briasoulis; Christos Pisiotis; Konstantinos Papazisis; Georgios Nasioulas
Inherited cancer predisposition syndromes in Greece.
Anticancer research 2008;28(2B):1341-7.
2008: Ioannis Sainis; Katerina Vareli; Vasilios Karavasilis; Evangelos Briasoulis
PPARgamma: The Portrait of a Target Ally to Cancer Chemopreventive Agents.
PPAR research 2008;2008():436489.
2008: Evangelia Razis; Evangelos Briasoulis; Eleni Vrettou; Dimosthenis V Skarlos; Dimitrios Papamichael; Ioannis Kostopoulos; Epaminontas Samantas; Ioannis Xanthakis; Mattheos Bobos; Eleni Galanidi; Maria Bai; Ioanna Gikonti; Alona Koukouma; Georgia Kafiri; Pavlos Papakostas; Konstantine T Kalogeras; Paris A Kosmidis; George Fountzilas
Potential value of PTEN in predicting cetuximab response in colorectal cancer: an exploratory study.
BMC cancer 2008;8():234.
2008: George Pentheroudakis; Evangelos Briasoulis; Haralabos P Kalofonos; George Fountzilas; Theofanis Economopoulos; Georgios Fotios Samelis; Aris Koutras; Maria Karina; Nikolaos Xiros; Epaminondas Samantas; Aristotelis Bamias; Nicholas Pavlidis
Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II study.
Acta oncologica (Stockholm, Sweden) 2008;47(6):1148-55.
2007: Markus Joerger; Alwin D R Huitema; Dick J Richel; Christian Dittrich; Nicholas Pavlidis; Evangelos Briasoulis; Jan B Vermorken; Elena Strocchi; Andrea Martoni; Roberto Sorio; Henk P Sleeboom; Miguel A Izquierdo; Duncan I Jodrell; Hilary Calvert; Alan V Boddy; Harry Hollema; Regine Féty; Wjf J F Van der Vijgh; Georg Hempel; Etienne Chatelut; Mats Karlsson; Justin Wilkins; Brigitte Tranchand; Ad H G J Schrijvers; Chris Twelves; Jos H Beijnen; Jan H M Schellens
Population pharmacokinetics and pharmacodynamics of paclitaxel and carboplatin in ovarian cancer patients: a study by the European organization for research and treatment of cancer-pharmacology and molecular mechanisms group and new drug development group.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(21):6410-8.
2007: Dimitrios H Roukos; Evangelos Briasoulis
Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.
Nature clinical practice. Oncology 2007;4(10):578-90.
2007: Evangelos Briasoulis; Michael Fatouros; Dimitrios H Roukos
Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?
Annals of surgical oncology 2007;14(10):2691-5.
2007: George Pentheroudakis; Evangelos Briasoulis; Nicholas Pavlidis
Cancer of unknown primary site: missing primary or missing biology?
The oncologist 2007;12(4):418-25.
2007: Dimitrios H Roukos; Samuel Murray; Evangelos Briasoulis
Molecular genetic tools shape a roadmap towards a more accurate prognostic prediction and personalized management of cancer.
Cancer biology & therapy 2007;6(3):308-12.
2007: Olympia Tzaida; Helen Gogas; Urania Dafni; Aspasia Kyroudi; IA Papaspyrou; Vasiliki Kyriakou; Vasiliki Malamou-Mitsi; Maria Alamani; Chrisoula Skopa; Ioannis Kostopoulos; Efstathios Kastritis; Dimitrios Pectasides; Evangelos Briasoulis; Haralabos P Kalofonos; Gerasimos Aravantinos; George Fountzilas; Petroula Arapantoni-Dadioti
Evaluation of the prognostic and predictive value of HER-1/EGFR in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.
Oncology 2007;72(5-6):388-96.
2007: Markus Joerger; Alwin D R Huitema; Dick J Richel; Christian Dittrich; Nikolas Pavlidis; Evangelos Briasoulis; Jan B Vermorken; Elena Strocchi; Andrea Martoni; Roberto Sorio; Henk P Sleeboom; Miguel A Izquierdo; Duncan I Jodrell; Régine Féty; Ernst de Bruijn; Georg Hempel; Mats Karlsson; Brigitte Tranchand; Ad H G J Schrijvers; Chris Twelves; Jos H Beijnen; Jan H M Schellens
Population pharmacokinetics and pharmacodynamics of doxorubicin and cyclophosphamide in breast cancer patients: a study by the EORTC-PAMM-NDDG.
Clinical pharmacokinetics 2007;46(12):1051-68.
2006: Evangelos Briasoulis; Vasilis Karavasilis; Eleftheria Tzamakou; Christina Piperidou; Kali Soulti; Nicholas Pavlidis
Feasibility study and pharmacokinetics of low-dose paclitaxel in cancer patients with severe hepatic dysfunction.
Anti-cancer drugs 2006;17(10):1219-22.
2006: Maria Bai; Konstantinos Katsanos; Michalis Economou; Sevasti Kamina; Christine Balli; Evangelos Briasoulis; Angelos M Kappas; Niki J Agnantis; Epameinondas V Tsianos
Rectal Epstein-Barr virus-positive Hodgkin's lymphoma in a patient with Crohn's disease: case report and review of the literature.
Scandinavian journal of gastroenterology 2006;41(7):866-9.
2006: Evangelos Briasoulis; Theodore Liakakos; Lefkothea Dova; Michael Fatouros; Pericles G Tsekeris; Dimitrios H Roukos; Angelos M Kappas
Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer.
Expert review of anticancer therapy 2006;6(6):931-9.
2006: Emilios Pakos; Pericles G Tsekeris; Evita J Pitouli; Stergiani P Gritzeli; Evangelos Briasoulis
Radical versus postoperative radiotherapy for localized prostate cancer: a 10-year experience of an academic hospital.
World journal of urology 2006;24(2):214-9.
2006: Nektaria Zagorianakou; Dimitrios Stefanou; George Makrydimas; P Zagorianakou; Evangelos Briasoulis; Vasilis Karavasilis; Nicholas Pavlidis; Niki J Agnantis
Clinicopathological study of metallothionein immunohistochemical expression, in benign, borderline and malignant ovarian epithelial tumors.
Histology and histopathology 2006;21(4):341-7.
2006: Vasilis Karavasilis; Vassiliki Malamou-Mitsi; Evangelos Briasoulis; Elena Tsanou; Evangelia Kitsou; Nicholas Pavlidis
Clinicopathologic study of vascular endothelial growth factor, thrombospondin-1, and microvessel density assessed by CD34 in patients with stage III ovarian carcinoma.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 1():241-6.
2006: Christos Christodoulou; Haralabos P Kalofonos; Evangelos Briasoulis; Dimitrios Bafaloukos; Thomas Makatsoris; Angelos Koutras; Dimosthenis V Skarlos; Epaminondas Samantas
Combination of topotecan and cisplatin in relapsed patients with small cell lung cancer: a phase II study of the hellenic cooperative oncology group (HeCOG).
Cancer chemotherapy and pharmacology 2006;57(2):207-12.
2005: Vasilis Karavasilis; Vassiliki Malamou-Mitsi; Evangelos Briasoulis; Elena Tsanou; Evangelia Kitsou; Haralambos Kalofonos; George Fountzilas; Theodore Fotsis; Nicholas Pavlidis
Matrix metalloproteinases in carcinoma of unknown primary.
Cancer 2005;104(10):2282-7.
2005: George Fountzilas; Dimosthenis Skarlos; Urania Dafni; Helen Gogas; Evangelos Briasoulis; Dimitrios Pectasides; Christos Papadimitriou; Christos Markopoulos; A Polychronis; Haralabos P Kalofonos; V Siafaka; Paris A Kosmidis; Eleni Timotheadou; Dimitrios Tsavdaridis; Dimitrios Bafaloukos; Pavlos Papakostas; Evangelia Razis; P Makrantonakis; Gerasimos Aravantinos; Christos Christodoulou; Athanassios Meletios Dimopoulos
Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(11):1762-71.
2005: Evangelos Briasoulis; Epaminondas Samantas; Haralambos Kalofonos; Dimosthenis Skarlos; Thomas Makatsoris; Christos Christodoulou; George Fountzilas; Aristotelis Bamias; M A Dimopoulos; Paris A Kosmidis; Nicholas Pavlidis
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer.
Cancer chemotherapy and pharmacology 2005;56(5):521-8.
2005: Periklis Pappas; Vasilis Karavasilis; Evangelos Briasoulis; Nicholas Pavlidis; Marios Marselos
Pharmacokinetics of imatinib mesylate in end stage renal disease. A case study.
Cancer chemotherapy and pharmacology 2005;56(4):358-60.
2005: George Fountzilas; Dimitrios Pectasides; Anna Kalogera-Fountzila; Dimosthenis Skarlos; Haralabos P Kalofonos; Christos Papadimitriou; Dimitrios Bafaloukos; Stefanos Lambropoulos; Savvas Papadopoulos; Helen P Kourea; Christos Markopoulos; Helena Linardou; Dimitrios Mavroudis; Evangelos Briasoulis; Nicholas Pavlidis; Evangelia Razis; Paris A Kosmidis; Helen Gogas
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group.
Breast cancer research and treatment 2005;92(1):1-9.
2005: Evangelos Briasoulis; DEMETRA RONTOGIANNI; Vasilis Karavasilis; Nicholas Pavlidis
Oxaliplatin (Eloxatin) plus irinotecan combination chemotherapy found effective in refractory metastatic insular thyroid carcinoma.
Thyroid : official journal of the American Thyroid Association 2005;15(6):614-7.
2005: George Pentheroudakis; Evangelos Briasoulis; V Karavassilis; Davide Mauri; Eleftheria Tzamakou; Dimitra Rammou; Nicholas Pavlidis
Phase I trial of intravenous cisplatin-topotecan chemotherapy for three consecutive days in patients with advanced solid tumors: parallel topotecan escalation in two fixed platinum dosing schemes.
Chemotherapy 2005;51(2-3):154-61.
2005: Dimitrios Pectasides; George Fountzilas; Gerasimos Aravantinos; Haralabos P Kalofonos; Eleni Efstathiou; Emmanuel Salamalekis; Dimitrios Farmakis; Dimosthenis Skarlos; Evangelos Briasoulis; Theofanis Economopoulos; Meletios A Dimopoulos
Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
Gynecologic oncology 2005;97(2):436-41.
2005: Vasilis Karavasilis; Vassiliki Malamou-Mitsi; Evangelos Briasoulis; Elena Tsanou; Evangelia Kitsou; Haralambos Kalofonos; George Fountzilas; Theodore Fotsis; Nicholas Pavlidis
Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1.
BMC cancer 2005;5():25.
2005: Evangelia Razis; Dimosthenis Skarlos; Evangelos Briasoulis; Meletios A Dimopoulos; George Fountzilas; S Lambropoulos; Sotiris K Rigatos; P Kopterides; H Efstathiou; Eleftheria Tzamakou; Chris N Bakoyannis; Dimitrios Pectasides; Thomas Makatsoris; G Varthalitis; Savvas Papadopoulos; Paris A Kosmidis
Treatment of non-small cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use program.
Anti-cancer drugs 2005;16(2):191-8.
2005: George Pentheroudakis; Evangelos Briasoulis; Vassilis Karavassilis; George Fountzilas; Nikolaos Xeros; Georgios Fotios Samelis; Epaminondas Samantas; Nicholas Pavlidis
Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: active, but how effective?
Acta oncologica (Stockholm, Sweden) 2005;44(2):155-60.
2004: Elena Tsanou; Elli Ioachim; Evangelos Briasoulis; Antonia Charchanti; Konstantina Damala; Vasilis Karavasilis; Nicholas Pavlidis; Niki J Agnantis
Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
Journal of experimental & clinical cancer research : CR 2004;23(4):641-50.
2004: George Pentheroudakis; Vassiliki Malamou-Mitsi; Evangelos Briasoulis; Konstantina Damala; Amalia Vassou; George Vartholomatos; Nikolaos Kolaitis; Nicholas Pavlidis
The neutrophil, not the tumor: serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy.
Cancer 2004;101(8):1767-75.
2004: Evangelos Briasoulis; George Pentheroudakis; Vasilis Karavasilis; Eleftheria Tzamakou; Dimitra Rammou; Nicholas Pavlidis
Weekly paclitaxel combined with pegylated liposomal doxorubicin (CaelyxTM) given every 4 weeks: dose-finding and pharmacokinetic study in patients with advanced solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(10):1566-73.
2004: George Fountzilas; Haralabos P Kalofonos; Urania Dafni; Christos Papadimitriou; Dimitrios Bafaloukos; Pavlos Papakostas; Anna Kalogera-Fountzila; Helen Gogas; Gerasimos Aravantinos; Lia A Moulopoulos; Theofanis Economopoulos; Dimitrios Pectasides; N Maniadakis; V Siafaka; Evangelos Briasoulis; Christos Christodoulou; Dimitrios Tsavdaridis; P Makrantonakis; Evangelia Razis; Paris A Kosmidis; Dimosthenis Skarlos; Meletios A Dimopoulos
Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(10):1517-26.
2004: Evangelos Briasoulis; Vasilis Karavasilis; Lida Kostadima; Michael Ignatiadis; George Fountzilas; Nicholas Pavlidis
Metastatic breast carcinoma confined to bone: portrait of a clinical entity.
Cancer 2004;101(7):1524-8.
2004: Evangelos Briasoulis; George Pentheroudakis; H Timotheadou; Dimitra Rammou; Nicholas Pavlidis; George Fountzilas
Biweekly administration of 24-h infusion of irinotecan followed by a 1-h infusion of docetaxel: a phase I study.
Anti-cancer drugs 2004;15(8):747-52.
2004: Elena Tsanou; Elli Ioachim; Evangelos Briasoulis; Konstantina Damala; Antonia Charchanti; Vasilis Karavasilis; Nicholas Pavlidis; Niki J Agnantis
Immunohistochemical expression of superoxide dismutase (MnSOD) anti-oxidant enzyme in invasive breast carcinoma.
Histology and histopathology 2004;19(3):807-13.
2004: Nektaria Zagorianakou; Dimitrios Stefanou; George Makrydimas; P Zagorianakou; Evangelos Briasoulis; B Karavasilis; Niki J Agnantis
CD44s expression, in benign, borderline and malignant tumors of ovarian surface epithelium. Correlation with p53, steroid receptor status, proliferative indices (PCNA, MIB1) and survival.
Anticancer research 2004;24(3a):1665-70.
2004: Evangelos Briasoulis; Vasilis Karavasilis; Eleftheria Tzamakou; Dimitra Rammou; Kali Soulti; Christina Piperidou; Nicholas Pavlidis
Interaction pharmacokinetics of pegylated liposomal doxorubicin (Caelyx) on coadministration with paclitaxel or docetaxel.
Cancer chemotherapy and pharmacology 2004;53(5):452-7.
2004: Giuseppe Giaccone; Egbert F Smit; M de Jonge; E Dansin; Evangelos Briasoulis; Andrea Ardizzoni; Jean-Yves Douillard; Dominique Spaeth; D Lacombe; B Baron; P Bachmann; Pierre Fumoleau
Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group.
European journal of cancer (Oxford, England : 1990) 2004;40(5):667-72.
2003: Evangelos Briasoulis; Nicholas Pavlidis; C Terret; J Bauer; W Fiedler; P Schöffski; J L Raoul; D Hess; R Selvais; D Lacombe; P Bachmann; Pierre Fumoleau
Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group.
European journal of cancer (Oxford, England : 1990) 2003;39(16):2334-40.
2003: Emilios Pakos; Pericles G Tsekeris; Evangelos Briasoulis
Recurrent prostate cancer: the role of salvage postoperative external radiotherapy in low risk patients.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2003;8(4):371-5.
2003: Nicholas Pavlidis; Evangelos Briasoulis; J Hainsworth; F A Greco
Diagnostic and therapeutic management of cancer of an unknown primary.
European journal of cancer (Oxford, England : 1990) 2003;39(14):1990-2005.
2003: Vasilis Karavasilis; Evangelos Briasoulis; Olga Siarabi; Nicholas Pavlidis
Biweekly administration of low-dose docetaxel in hormone-resistant prostate cancer: pilot study of an effective subtoxic therapy.
Clinical prostate cancer 2003;2(1):46-9.
2003: Evangelos Briasoulis; Evangelia Tzouvara; Stavroula Tsiara; Giorgos Vartholomatos; Pericles G Tsekeris; Konstantinos L Bourantas
Biphenotypic acute leukemia following intensive adjuvant chemotherapy for breast cancer: case report and review of the literature.
The breast journal 2003;9(3):241-5.
2003: Elli Ioachim; Elena Tsanou; Evangelos Briasoulis; Ch Batsis; Vasilis Karavasilis; Antonia Charchanti; Nicholas Pavlidis; Niki J Agnantis
Clinicopathological study of the expression of hsp27, pS2, cathepsin D and metallothionein in primary invasive breast cancer.
Breast (Edinburgh, Scotland) 2003;12(2):111-9.
2003: Dimitrios H Roukos; Evangelos Briasoulis; Konstantinos M Michos; Moses Elisaf; Niki J Agnantis; Angelos M Kappas
Breast and gastric cancer: comparing what we learn.
Annals of surgical oncology 2003;10(1):92-4.
2002: Elli Ioachim; Antonia Charchanti; Evangelos Briasoulis; Vasilis Karavasilis; H Tsanou; Dimitrios Arvanitis; Niki J Agnantis; Nicholas Pavlidis
Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression.
European journal of cancer (Oxford, England : 1990) 2002;38(18):2362-70.
2002: Evangelos Briasoulis; Vasilis Karavasilis; Eleftheria Tzamakou; Constantina Haidou; Christina Piperidou; Nicholas Pavlidis
Pharmacodynamics of non-break weekly paclitaxel (Taxol) and pharmacokinetics of Cremophor-EL vehicle: results of a dose-escalation study.
Anti-cancer drugs 2002;13(5):481-9.
2002: Dimitrios Bafaloukos; Gerasimos Aravantinos; George Fountzilas; George P Stathopoulos; Helen Gogas; G Samonis; Evangelos Briasoulis; Nicolas Mylonakis; Dimosthenis V Skarlos; Paris A Kosmidis
Docetaxel in combination with dacarbazine in patients with advanced melanoma.
Oncology 2002;63(4):333-7.
2001: Evangelos Briasoulis; Niki J Agnantis; P Zagorianakou; Sevasti Kamina; M Gorezi; Nicholas Pavlidis; Maria Bai
Near-absolute expression of the bcl-2 protein identifies a subgroup of stage II breast cancer patients with a most favorable outcome. Results of a clinicopathological study.
Journal of experimental & clinical cancer research : CR 2001;20(3):341-4.
2001: Evangelos Briasoulis; Eleni Andreopoulou; Christos Tolis; Eleni Bairaktari; Afroditi Katsaraki; Meletios A Dimopoulos; George Fountzilas; C Seferiadis; Nicholas Pavlidis
G-CSF induces elevation of circulating CA 15-3 in breast carcinoma patients treated in an adjuvant setting.
Cancer 2001;91(5):909-17.
2001: Marios E Froudarakis; Olivier Tiffet; Pierre Fournel; Evangelos Briasoulis; Vasilis Karavasilis; Jacques Cuilleret; Jean-Michel Vergnon
Invasive thymoma: a clinical study of 23 cases.
Respiration; international review of thoracic diseases 2001;68(4):376-81.
2001: Evangelos Briasoulis; Nicholas Pavlidis
Noncardiogenic pulmonary edema: an unusual and serious complication of anticancer therapy.
The oncologist 2001;6(2):153-61.
2000: Evangelos Briasoulis; I Judson; Nicholas Pavlidis; P Beale; Jantien Wanders; Y Groot; G Veerman; M Schuessler; G Niebch; K Siamopoulos; Eleftheria Tzamakou; Dimitra Rammou; L Wolf; R Walker; Axel R Hanauske
Phase I trial of 6-hour infusion of glufosfamide, a new alkylating agent with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters: a study of the European Organization for Research and Treatment of Cancer Early Clinical Studies Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(20):3535-44.
2000: Evangelos Briasoulis; Haralambos Kalofonos; Dimitrios Bafaloukos; Epaminondas Samantas; George Fountzilas; Nikolaos Xiros; Dimosthenis Skarlos; C Christodoulou; Paris A Kosmidis; Nicholas Pavlidis
Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(17):3101-7.
2000: Evangelos Briasoulis; Vasilis Karavasilis; Nicholas Pavlidis
Successful rechallenge with taxanes following prophylactic ketotifen in patients who had developed severe hypersensitivity reactions.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(7):899.
2000: Evangelos Briasoulis; Marios E Froudarakis; H J Milionis; I Peponis; Stavros H Constantopoulos; Nicholas Pavlidis
Chemotherapy-induced noncardiogenic pulmonary edema related to gemcitabine plus docetaxel combination with granulocyte colony-stimulating factor support.
Respiration; international review of thoracic diseases 2000;67(6):680-3.
1999: Evangelos Briasoulis; Vasilis Karavasilis; Dimitri Anastasopoulos; Eleftheria Tzamakou; George Fountzilas; Dimitra Rammou; V Kostadima; Nicholas Pavlidis
Weekly docetaxel in minimally pretreated cancer patients: a dose-escalation study focused on feasibility and cumulative toxicity of long-term administration.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(6):701-6.
1999: George Fountzilas; A Zisiadis; Urania Dafni; Christos Konstantaras; G Hatzitheoharis; A Liaros; Eleni Athanassiou; Nicholas V Dombros; Christos Dervenis; George Basdanis; Orestis G Gamvros; A Souparis; Evangelos Briasoulis; Epaminondas Samantas; Angelos M Kappas; Paris A Kosmidis; Dimosthenis Skarlos; Nicholas Pavlidis
Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(6):671-6.
1998: Evangelos Briasoulis; N Tsavaris; George Fountzilas; A Athanasiadis; P Kosmidis; D Bafaloukos; D Skarlos; Epaminondas Samantas; Nicholas Pavlidis
Combination regimen with carboplatin, epirubicin and etoposide in metastatic carcinomas of unknown primary site: A Hellenic Co-Operative Oncology Group Phase II Study.
Oncology 1998;55(5):426-30.
1998: Leonidas Christou; Stavroula Tsiara; Y Frangides; J Pnevmatikos; Evangelos Briasoulis; E Galanakis; Konstantinos L Bourantas
Patients with multiple myeloma and solid tumors: six case reports.
Journal of experimental & clinical cancer research : CR 1998;17(2):239-42.
1997: George Fountzilas; A Athanassiades; THEODORE GIANNAKAKIS; Evangelos Briasoulis; Dimitrios Bafaloukos; Anna Kalogera-Fountzila; A Onienaoum; Haralambos Kalofonos; Dimitrios Pectasides; Eleni Andreopoulou; Christina Bamia; Paris A Kosmidis; Nicholas Pavlidis; Dimosthenis Skarlos
A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(12):1213-20.
1997: George Fountzilas; AP Athanassiadis; Anna Kalogera-Fountzila; Gerasimos Aravantinos; Dimitrios Bafaloukos; Evangelos Briasoulis; Nicholas V Dombros; Ioannis Ioannidis; Nicholas Pavlidis; Paris A Kosmidis; Dimosthenis Skarlos
Paclitaxel by 3-h infusion and carboplatin in anthracycline-resistant advanced breast cancer. A phase II study conducted by the Hellenic Cooperative Oncology Group.
European journal of cancer (Oxford, England : 1990) 1997;33(11):1893-5.
1997: Evangelos Briasoulis; Vasilis Karavasilis; Nicholas Pavlidis
Megestrol activity in recurrent adult type granulosa cell tumour of the ovary.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(8):811-2.
1997: George Fountzilas; Dimosthenis Skarlos; A Athanassiades; Anna Kalogera-Fountzila; Epaminondas Samantas; Christos Bacoyiannis; Angelos Nicolaou; Nicholas V Dombros; Evangelos Briasoulis; M Dinopoulou; George P Stathopoulos; Nicholas Pavlidis; Paris A Kosmidis; John Daniilidis
Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck. A phase II study conducted by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(5):451-5.
1994: Nicolas Tsavaris; Nicolas Mylonakis; N Karvounis; Christos Bacoyiannis; Evangelos Briasoulis; D Skarlos; Nicholas Pavlidis; G Stamatelos; Paris A Kosmidis
Combination chemotherapy with cisplatin-vinblastine in malignant mesothelioma.
Lung cancer (Amsterdam, Netherlands) 1994;11(3-4):299-303.